tiprankstipranks
Quantum Genomics (QNNTF)
OTHER OTC:QNNTF

Quantum Genomics (QNNTF) Financial Statements

5 Followers

Quantum Genomics Financial Overview

Quantum Genomics's market cap is currently ―. The company's EPS TTM is $-0.099; its P/E ratio is -1.27; Quantum Genomics is scheduled to report earnings on March 28, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Dec 21Jun 21Dec 20Jun 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments€ 19.58M€ 13.55M€ 24.87M€ 27.15M€ 13.19M
Total Assets€ 27.06M€ 22.59M€ 32.42M€ 34.95M€ 18.55M
Total Debt€ 3.40M€ 3.00M€ 3.00M€ 3.74K€ 2.35M
Net Debt€ -16.19M€ -10.55M€ -21.87M€ -27.15M€ -10.84M
Total Liabilities€ 11.72M€ 11.00M€ 10.33M€ 7.10M€ 7.24M
Stockholders Equity€ 15.34M€ 11.59M€ 22.08M€ 27.86M€ 11.31M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in EUR

Quantum Genomics Earnings and Revenue History

Quantum Genomics Debt to Assets

Quantum Genomics Cash Flow

Quantum Genomics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis